Ergoteles’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,250
Closed -$576K 2028
2022
Q3
$576K Buy
8,250
+2,824
+52% +$197K 0.02% 703
2022
Q2
$364K Buy
5,426
+986
+22% +$66.1K 0.01% 1005
2022
Q1
$365K Sell
4,440
-10,391
-70% -$854K 0.01% 779
2021
Q4
$2.18M Sell
14,831
-51,031
-77% -$7.49M 0.08% 243
2021
Q3
$11.7M Sell
65,862
-44,138
-40% -$7.81M 0.43% 55
2021
Q2
$17.8M Buy
110,000
+97,800
+802% +$15.8M 0.41% 43
2021
Q1
$2.09M Buy
+12,200
New +$2.09M 0.07% 275